Clinical Trial Update: Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome [NA]

View source ↗

Summary

A clinical trial evaluating low-dose naltrexone for juvenile primary fibromyalgia syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: Stanford University | Conditions: Fibromyalgia | NA | Status: WITHDRAWN